OBIO·68572M106·US·equity·Healthcare - Biotechnology-Activist
OBIO (ORCHESTRA BIOMED HLDGS INC) is held by 36 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($35.3M), Alyeska Investment Group, L.P. ($4.3M), MILLENNIUM MANAGEMENT LLC ($3M). Net institutional sentiment: Mixed.
See how OBIO's score breaks down across 4 SEC sources
Showing 1-20 of 49
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer